Citations (64)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Yuanchao Zhu, Fei Zhao & Pengfei Jin. (2023) Clinical Manifestations and Risk Factors of Tigecycline-Associated Thrombocytopenia. Infection and Drug Resistance 16, pages 6225-6235.
Read now
Read now
Hong Zhou, Xiangyu Sun, Shaocheng Lyu, Xiaojia Yu, Ran Li, Huaguang Wang & Zhuoling An. (2023) Evaluation of Tigecycline Utilization and Trends in Antibacterial Resistance from 2018 to 2021 in a Comprehensive Teaching Hospital in China. Infection and Drug Resistance 16, pages 879-889.
Read now
Read now
Jiaju Zhuo, Beibei Liang, Huan Zhang, Yulong Chi & Yun Cai. (2023) An overview of gram-negative bacteria with difficult-to-treat resistance: definition, prevalence, and treatment options. Expert Review of Anti-infective Therapy 21:11, pages 1203-1212.
Read now
Read now
Haibo Lei, Xiang Liu, Zuojun Li & Chunjiang Wang. (2023) Analysis of the clinical characteristics of tigecycline-induced hypofibrinogenemia. Journal of Chemotherapy 35:4, pages 292-297.
Read now
Read now
Xiaoli Lin, Xinyu Liu, Xiaoying Wu, Xishao Xie, Guangjun Liu, Jianyong Wu, Wenhan Peng, Rending Wang, Jianghua Chen & Hongfeng Huang. (2023) Wide-spectrum antibiotic prophylaxis guarantees optimal outcomes in drowned donor kidney transplantation. Expert Review of Anti-infective Therapy 21:2, pages 203-211.
Read now
Read now
Ning Du, En-Qiang Mao, Zhi-Tao Yang, Hong-Ping Qu, Xian Qian, Ying Shi, Xiao-Lan Bian, Juan He & Er-Zhen Chen. (2022) Intrathecal or Intraventricular Tigecycline Therapy for Central Nervous System Infection Associated with Carbapenem-Resistant Klebsiella pneumoniae. Infection and Drug Resistance 15, pages 7219-7226.
Read now
Read now
Matteo Bassetti, Antonio Falletta, Giovanni Cenderello, Daniele R. Giacobbe & Antonio Vena. (2022) Safety evaluation of current therapies for high-risk severely ill patients with carbapenem-resistant infections. Expert Opinion on Drug Safety 21:4, pages 487-498.
Read now
Read now
Gianpaolo Perletti, Alberto Trinchieri, Konstantinos Stamatiou & Vittorio Magri. (2022) Safety considerations with new antibacterial approaches for chronic bacterial prostatitis. Expert Opinion on Drug Safety 21:2, pages 171-182.
Read now
Read now
X Li, L Li, T Liu, X Hai & B Sun. (2021) Leukocytosis induced by tigecycline in two patients with severe acute pancreatitis. British Journal of Biomedical Science 78:4, pages 225-228.
Read now
Read now
Adrian Ceccato, Pierluigi Di Giannatale, Stefano Nogas & Antoni Torres. (2021) Safety considerations of current drug treatment strategies for nosocomial pneumonia. Expert Opinion on Drug Safety 20:2, pages 181-190.
Read now
Read now
Aneela Majeed, Sumaiah Alarfaj, Rabih Darouiche & Mayar Mohajer. (2017) An update on emerging therapies for urinary tract infections. Expert Opinion on Emerging Drugs 22:1, pages 53-62.
Read now
Read now
Articles from other publishers (53)
Shaqiu Zhang, Jinfeng Wen, Yuwei Wang, Zhijun Zhong, Mingshu Wang, Renyong Jia, Shun Chen, Mafeng Liu, Dekang Zhu, Xinxin Zhao, Ying Wu, Qiao Yang, Juan Huang, Xumin Ou, Sai Mao, Qun Gao, Di Sun, Bin Tian & Anchun Cheng. (2023) Decoding the enigma: unveiling the molecular transmission of avian-associated tet(X4)-positive E. coli in Sichuan Province, China. Poultry Science 102:12, pages 103142.
Crossref
Crossref
Bansi Rakholiya, Priyangi Shah, Yash Patel, Gayatri Patel, Samir Patel & Archita Patel. (2023) A Review on Analytical Methods for Tigecycline Estimation From Its Bulk and Dosage Form. Journal of AOAC International 106:6, pages 1689-1695.
Crossref
Crossref
Andrew M Skinner, Laurica A Petrella, Adam Cheknis & Stuart Johnson. (2023)
Antimicrobial susceptibility of
Clostridioides difficile
to omadacycline and comparator antimicrobials
. Journal of Antimicrobial Chemotherapy 78:7, pages 1779-1784.
Crossref
Crossref
João Pedro Rueda Furlan & Eliana Guedes Stehling. (2023) Predicting tigecycline susceptibility in multidrug-resistant Klebsiella species and Escherichia coli strains of environmental origin. Brazilian Journal of Microbiology.
Crossref
Crossref
Yan Zhang, Jie Zhang, Ping Cai, Yang Lu, Ruan-Yang Sun, Meng-Tao Cao, Xiao-Li Xu, Mark A. Webber & Hong-Xia Jiang. (2023) IncHI1 plasmids are epidemic vectors that mediate transmission of tet(X4) in Escherichia coli isolated from China. Frontiers in Microbiology 14.
Crossref
Crossref
Khadijeh Delroba, Maryam Alaei & Hossein Khalili. (2023) Treatment options for infections caused by multidrug-resistant Gram-negative bacteria: a guide to good clinical practice. Future Microbiology 18:5, pages 287-294.
Crossref
Crossref
Bilal Aslam, Moeed Ahmad, Muhammad Usama Tariq, Saima Muzammil, Abu Baker Siddique, Mohsin Khurshid, Aqsa Shahid, Muhammad Hidayat Rasool, Tamoor Hamid Chaudhry, Afreenish Amir, Muhammad Salman & Zulqarnain Baloch. 2023. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources. Degradation of Antibiotics and Antibiotic-Resistant Bacteria from Various Sources
1
37
.
Mikaela M. Walker, Jason A. Roberts, Benjamin A. Rogers, Patrick N. A. Harris & Fekade B. Sime. (2022) Current and Emerging Treatment Options for Multidrug Resistant Escherichia coli Urosepsis: A Review. Antibiotics 11:12, pages 1821.
Crossref
Crossref
Lin Zhu, Yulu Lian, Da Lin, Guoping Lin & Meizhen Wang. (2022) The profile and persistence of clinically critical antibiotic resistance genes and human pathogenic bacteria in manure-amended farmland soils. Frontiers in Cellular and Infection Microbiology 12.
Crossref
Crossref
Fernando Soler DelgadoEnrique Juan DíazGreeneFederico Leopoldo Rodriguez-WeberSuria Elizabeth Loza-JalilQuitzia Libertad Torres-Salazar*. (2022) INCIDENCE OF TRIMETHOPRIM-SULFAMETHOXAZOLE RESISTANT S. MALTOPHILIA INFECTIONS IN A MEXICO CITY HOSPITAL.. GLOBAL JOURNAL FOR RESEARCH ANALYSIS, pages 33-35.
Crossref
Crossref
Tingting Jiang, Xuhui Huang, Qinghua Liu, Hangwei Feng, Yiting Huang, Jian Lin, Long Huang, Shufang Chen, Yingfeng Zhuang & Cuilian Weng. (2022) Risk Factors for Tigecycline‐Associated Hepatotoxicity in Patients in the Intensive Care Units of 2 Tertiary Hospitals: A Retrospective Study. The Journal of Clinical Pharmacology 62:11, pages 1426-1434.
Crossref
Crossref
Sandra Doß, Corinne Blessing, Katharina Haller, Georg Richter & Martin Sauer. (2022) Influence of Antibiotics on Functionality and Viability of Liver Cells In Vitro. Current Issues in Molecular Biology 44:10, pages 4639-4657.
Crossref
Crossref
Xiaoxuan Yang, Lu Jin, Xuemei Luo, Min Wang, Huaijun Zhu, Yujie Zhou & Weihong Ge. (2022) Serum concentration as a predictor of tigecycline-induced hypofibrinogenemia in critically ill patients: A retrospective cohort study. International Journal of Infectious Diseases 123, pages 136-142.
Crossref
Crossref
Shaqiu Zhang, Jinfeng Wen, Yuwei Wang, Mingshu Wang, Renyong Jia, Shun Chen, Mafeng Liu, Dekang Zhu, Xinxin Zhao, Ying Wu, Qiao Yang, Juan Huang, Xumin Ou, Sai Mao, Qun Gao, Di Sun, Bin Tian & Anchun Cheng. (2022) Dissemination and prevalence of plasmid-mediated high-level tigecycline resistance gene tet (X4). Frontiers in Microbiology 13.
Crossref
Crossref
Sajad Yaghoubi, Angelina Olegovna Zekiy, Marcela Krutova, Mehrdad Gholami, Ebrahim Kouhsari, Mohammad Sholeh, Zahra Ghafouri & Farajolah Maleki. (2021) Tigecycline antibacterial activity, clinical effectiveness, and mechanisms and epidemiology of resistance: narrative review. European Journal of Clinical Microbiology & Infectious Diseases 41:7, pages 1003-1022.
Crossref
Crossref
Dai Kurihara, Satoru Matsumoto, Naoko Kishi, Yoshikazu Ishii & Masahiko Mori. (2022)
In Vitro
Antibacterial Activity of Imipenem/Relebactam against Clinical Isolates in Japan
. Microbiology Spectrum 10:2.
Crossref
Crossref
Tasvi Daya, Olamide Jeje, Reabetswe Maake, Chinyere Aloke, Thandeka Khoza & Ikechukwu Achilonu. (2022) Expression, Purification, and Biophysical Characterization of Klebsiella Pneumoniae Nicotinate Nucleotide Adenylyltransferase. The Protein Journal 41:1, pages 141-156.
Crossref
Crossref
Ivana Ćirković & Milena Švabić-Vlahović. (2022) Nosocomial antibiotic strain resistance. Galenika Medical Journal 1:3, pages 60-68.
Crossref
Crossref
I-Hao Lin & Chun-Hao Tsai. (2021) Tigecycline sclerotherapy for recurrent pseudotumor in aseptic lymphocyte-dominant vasculitis-associated lesion after metal-on-metal total hip arthroplasty: A case report. World Journal of Clinical Cases 9:34, pages 10696-10701.
Crossref
Crossref
Aura Rusu & Emanuela Lorena Buta. (2021) The Development of Third-Generation Tetracycline Antibiotics and New Perspectives. Pharmaceutics 13:12, pages 2085.
Crossref
Crossref
Therese M. DuaneJared M. HustonMorgan CollomAdam BeyerSara ParliSara BuckmanMark ShapiroAmy McDonaldJose DiazJeffrey M. TessierJames Sanders. (2021) Surgical Infection Society 2020 Updated Guidelines on the Management of Complicated Skin and Soft Tissue Infections. Surgical Infections 22:4, pages 383-399.
Crossref
Crossref
Niccolò RiccardiJacopo MonticelliRoberta Maria AntonelloGustavo Di LalloDomenico FrezzaRoberto LuzzatiStefano Di Bella. (2021) Therapeutic Options for Infections Due to vanB Genotype Vancomycin-Resistant Enterococci. Microbial Drug Resistance 27:4, pages 536-545.
Crossref
Crossref
Junyan Qu, Chunlu Feng, Huan Li & Xiaoju Lv. (2021) Antibiotic strategies and clinical outcomes for patients with carbapenem-resistant Gram-negative bacterial bloodstream infection. International Journal of Antimicrobial Agents 57:3, pages 106284.
Crossref
Crossref
Rong Zhang, Ning Dong, Zhangqi Shen, Yu Zeng, Jiauyue Lu, Congcong Liu, Hongwei Zhou, Yanyan Hu, Qiaoling Sun, Qipeng Cheng, Lingbing Shu, Jiachang Cai, Edward Wai-Chi Chan, Gongxiang Chen & Sheng Chen. (2020) Epidemiological and phylogenetic analysis reveals Flavobacteriaceae as potential ancestral source of tigecycline resistance gene tet(X). Nature Communications 11:1.
Crossref
Crossref
Selliamman Palaniyandi Nallusamy Sharavanan, Chidambaram Subramanian Venkatesan, Singaram Sathiyanarayanan & Senthamaraikannan Kabilan. (2020) Potential Impurities of Tigecycline: Synthesis, Isolation, Characterization and In Vitro Pharmacological Evaluation. Current Pharmaceutical Analysis 16:6, pages 730-742.
Crossref
Crossref
Juan Hu, Yong-hong Xiao, Yi Zheng, Yang-xiao Lai, Xue-ling Fang & Qiang Fang. (2020) Clinical characteristics and risk factors of tigecycline-associated hypofibrinogenaemia in critically ill patients. European Journal of Clinical Pharmacology 76:7, pages 913-922.
Crossref
Crossref
David M. P. De Oliveira, Brian M. Forde, Timothy J. Kidd, Patrick N. A. Harris, Mark A. Schembri, Scott A. Beatson, David L. Paterson & Mark J. Walker. (2020) Antimicrobial Resistance in ESKAPE Pathogens. Clinical Microbiology Reviews 33:3.
Crossref
Crossref
Subramanian Swaminathan & Prithwijit Kundu. (2021) Tigecycline: Role in the Management of cIAI and cSSTI in the Indian Context. Indian Journal of Clinical Medicine 10:1-2, pages 24-30.
Crossref
Crossref
Yihan Mao, Qiucheng Shi, Ping Zhang, Yan Jiang & Yunsong Yu. (2020) Effect of ramR loss-of-function insertion on tigecycline resistance in clinical isolates of carbapenem-resistant Klebsiella pneumoniae. Journal of Global Antimicrobial Resistance 21, pages 410-413.
Crossref
Crossref
Lei Zha, Lingling Pan, Jun Guo, Neil French, Elmer V. Villanueva & Boris Tefsen. (2020) Effectiveness and Safety of High Dose Tigecycline for the Treatment of Severe Infections: A Systematic Review and Meta-Analysis. Advances in Therapy 37:3, pages 1049-1064.
Crossref
Crossref
David Aguilera-Alonso, Luis Escosa-García, Jesús Saavedra-Lozano, Emilia Cercenado & Fernando Baquero-Artigao. (2020) Carbapenem-Resistant Gram-Negative Bacterial Infections in Children. Antimicrobial Agents and Chemotherapy 64:3.
Crossref
Crossref
Jesus Ruiz, Paula Ramirez, Esther Villarreal, Mónica Gordon, María Ángeles Sánchez, María Martín & Álvaro Castellanos-Ortega. (2020) Effect of pharmacokinetic/pharmacodynamic ratio on tigecycline clinical response and toxicity in critically ill patients with multidrug-resistant Gram-negative infections. SAGE Open Medicine 8, pages 205031212095889.
Crossref
Crossref
Kai Ming Chow, Wing Fai Pang, Gordon Chun Kau Chan, Chi Bon Leung, Cheuk Chun Szeto & Philip Kam Tao Li. (2019) Beware of drug interaction between tigecycline and tacrolimus. Nephrology 25:1, pages 99-100.
Crossref
Crossref
Qiaomei Fan, Wei Huang, Yayun Weng, Xianze Xie & Zheng Shi. (2020) Hypofibrinogenemia induced by high-dose tigecycline—case report and review of literature. Medicine 99:43, pages e22638.
Crossref
Crossref
Yuehua Wang, Fei Xie, Dejie Chen & Ling Wang. (2019) Inhibition of mitochondrial respiration by tigecycline selectively targets thyroid carcinoma and increases chemosensitivity. Clinical and Experimental Pharmacology and Physiology 46:10, pages 890-897.
Crossref
Crossref
Yong-Soo Kwon, Adrah Levin, Shannon H. Kasperbauer, Gwen A. Huitt & Charles L. Daley. (2019) Efficacy and safety of tigecycline for Mycobacterium abscessus disease. Respiratory Medicine 158, pages 89-91.
Crossref
Crossref
Xiaoying Zheng, Huiming Jiang, Lifen Xue, Feng Qiu, Shenyin Zhu & Xinyu Li. (2019) Delirium induced by tigecycline treatment for Acinetobacter baumannii infection. Medicine 98:19, pages e15399.
Crossref
Crossref
Cheng Peng, Xiaofeng Wang, Jiangwei Zhang, Yi Jiang & Xinlin Hou. (2018) Tigecycline application in a 3-month-old infant with multiple drug resistant Klebsiella pneumonia: a case report. Gut Pathogens 10:1.
Crossref
Crossref
Jeffrey AS Ritsema, Hessel van der Weide, Yvonne M te Welscher, Wil HF Goessens, Cornelus F van Nostrum, Gert Storm, Irma AJM Bakker-Woudenberg & John P Hays. (2018) Antibiotic-nanomedicines: facing the challenge of effective treatment of antibiotic-resistant respiratory tract infections. Future Microbiology 13:15, pages 1683-1692.
Crossref
Crossref
Ying Xiong, Wei Liu, Qian Huang, Jierong Wang, Yanjun Wang, Huijuan Li & Xuedong Fu. (2018) Tigecycline as a dual inhibitor of retinoblastoma and angiogenesis via inducing mitochondrial dysfunctions and oxidative damage. Scientific Reports 8:1.
Crossref
Crossref
Nashaat S. Hamza & Abdalla Khalil. 2018. Urinary Tract Infection - The Result of the Strength of the Pathogen, or the Weakness of the Host. Urinary Tract Infection - The Result of the Strength of the Pathogen, or the Weakness of the Host.
Xiaoqin Wu, Ping Zhao, Liang Dong & Xiuhong Zhang. (2017) A case report of patient with severe acute cholangitis with tigecycline treatment causing coagulopathy and hypofibrinogenemia. Medicine 96:49, pages e9124.
Crossref
Crossref
Yu-Qing Fang, Ru-Cai Zhan, Wei Jia, Bao-Qing Zhang & Jian-Jun Wang. (2017) A case report of intraventricular tigecycline therapy for intracranial infection with extremely drug resistant Acinetobacter baumannii. Medicine 96:31, pages e7703.
Crossref
Crossref
Bo Wang, Jinsong Ao, Dan Yu, Ting Rao, Yuan Ruan & Xiaobin Yao. (2017) Inhibition of mitochondrial translation effectively sensitizes renal cell carcinoma to chemotherapy. Biochemical and Biophysical Research Communications 490:3, pages 767-773.
Crossref
Crossref
Zhengyi Cao, Theodore Spilker, Yongyi Fan, Linda M Kalikin, Susan Ciotti, John J LiPuma, Paul E Makidon, John Erby Wilkinson, James R BakerJrJr & Su He Wang. (2017)
Nanoemulsion is an effective antimicrobial for methicillin-resistant
Staphylococcus aureus
in infected wounds
. Nanomedicine 12:10, pages 1177-1185.
Crossref
Crossref
Ha Na LeeHana Yoon. (2017) Management of Antibiotic-Resistant Acute Pyelonephritis. Urogenital Tract Infection 12:3, pages 95.
Crossref
Crossref
Jun Tan, Meijun Song, Mi Zhou & Yaoren Hu. (2017) Antibiotic tigecycline enhances cisplatin activity against human hepatocellular carcinoma through inducing mitochondrial dysfunction and oxidative damage. Biochemical and Biophysical Research Communications 483:1, pages 17-23.
Crossref
Crossref
Cuixiang Sun & Xiao-Yi Xiao. 2018. Antibacterials. Antibacterials
55
95
.
Xuefeng Jia, Zhenfang Gu, Wenming Chen & Junbo Jiao. (2016) Tigecycline targets nonsmall cell lung cancer through inhibition of mitochondrial function. Fundamental & Clinical Pharmacology 30:4, pages 297-306.
Crossref
Crossref
Francisco Molina, Carlos Andrés Agudelo, Nelson Fonseca, Alicia Hidrón Botero, Carlos Andrés Jiménez, Álvaro Ochoa, Carlos Andrés Restrepo, Iván Mauricio Trompa & Gustavo Roncancio. (2016) Farmacocinética y farmacodinamia de los antibióticos en el paciente críticamente enfermo. Segunda parte. Acta Colombiana de Cuidado Intensivo 16:3, pages 156-171.
Crossref
Crossref
Fan Liu & Andrew G Myers. (2016) Development of a platform for the discovery and practical synthesis of new tetracycline antibiotics. Current Opinion in Chemical Biology 32, pages 48-57.
Crossref
Crossref
Kathleen Chiotos, Jennifer H. Han & Pranita D. Tamma. (2015) Carbapenem-Resistant Enterobacteriaceae Infections in Children. Current Infectious Disease Reports 18:1.
Crossref
Crossref
Hui Li, Shun Jiao, Xin Li, Hasina Banu, Shreejana Hamal & Xianrong Wang. (2015) Therapeutic effects of antibiotic drug tigecycline against cervical squamous cell carcinoma by inhibiting Wnt/β-catenin signaling. Biochemical and Biophysical Research Communications 467:1, pages 14-20.
Crossref
Crossref